MR lymphangiography using dendrimer-based contrast agents: A comparison at 1.5T and 3.0T

Magnetic Resonance in Medicine

Volumn 57, Issue 2, 2007, Pages 431-436

  Hama, Yukihiro ^a   Bernardo, Marcelino ^b   Regino, Celeste A S ^a   Koyama, Yoshinori ^a   Brechbiel, Martin W ^a   Krishna, Murali C ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Contrast media; Lymphatic; Macromolecule; Relaxivity; Sentinel lymph node

Indexed keywords

ANGIOGRAPHY; DENDRIMERS; MACROMOLECULES; MAMMALS;

CONTRAST AGENT; FAST IMAGING EMPLOYING STEADY-STATE ACQUISITIONS; GRADIENT ECHO; LYMPHATIC; PHASE CYCLING; RELAXIVITY; SENTINEL LYMPH NODES; SIGNAL INTENSITIES;

CONTRAST MEDIA;

2 (4 ISOTHIOCYANATOBENZYL) 6 METHYLPENTETIC ACID; CONTRAST MEDIUM; DENDRIMER; GADOLINIUM PENTETATE DERIVATIVE; PENTETIC ACID DERIVATIVE; POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; IMAGE ANALYSIS; INJECTION SITE; LYMPH NODE; LYMPHANGIOGRAPHY; MACROMOLECULE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; STEADY STATE;

EID: 33846813906     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21126     Document Type: Article

References (19)

1. Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 2004;96:703-708.
2. Kobayashi H, Sato N, Hiraga A, Saga T, Nakamoto Y, Ueda H, Konishi J, Togashi K, Brechbiel MW. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med 2001;45:454-460.
3. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 2003;63:271-276.
4. Zhou Z, Guo J, Yu H, Zhu B, Liu C, Jiang X, Zhang M, Chen J. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits. J Magn Reson Imaging 2005;22:361-367.
5. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.
6. Barboriak DP, Padua AO, York GE, Macfall JR. Creation of DICOM - aware applications using ImageJ. J Digit Imaging 2005;18:91-99.
7. Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL. Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. Neoplasia 2005;7:984-991.
8. Scheffler K, Lehnhardt S. Principles and applications of balanced SSFP techniques. Eur Radiol 2003;13:2409-2418.
9. Lin W, An H, Chen Y, Nicholas P, Zhai G, Gerig G, Gilmore J, Bullitt E. Practical consideration for 3T imaging. Magn Reson Imaging Clin N Am 2003;11:615-639.
10. Scarabino T, Nemore F, Giannatempo GM, Bertolino A, Di Salle F, Salvolini U. 3.0 T magnetic resonance in neuroradiology. Eur J Radiol 2003;4:154-164.
11. Krautmacher C, Willinek WA, Tschampa HJ, Born M, Traber F, Gieseke J, Textor HJ, Schild HH, Kuhl CK. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T - initial experience. Radiology 2005;237:1014-1019.
12. Trattnig S, Ba-Ssalamah A, Noebauer-Huhmann IM, Barth M, Wolfsberger S, Pinker K, Knosp E. MR contrast agent at high-field MRI (3 Tesla). Top Magn Reson Imaging 2003;14:365-375.
13. Nobauer-Huhmann IM, Ba-Ssalamah A, Mlynarik V, Barth M, Schoggl A, Heimberger K, Matula C, Fog A, Kaider A, Trattnig S. Magnetic resonance imaging contrast enhancement of brain tumors at 3 Tesla versus 1.5 Tesla. Invest Radiol 2002;373:114-119.
14. Kobayashi H, Brechbiel MW. Dendrimer-based nanosized MRI contrast agents. Curr Pharm Biotechnol 2004;5:539-549.
15. Lee CC, Mackay JA, Frechet JM, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol 2005;23:1517-1526.
16. Kobayashi H, Brechbiel MW. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 2005;57:2271-2286.
17. Suga K, Yuan Y, Okada M, Matsunaga N, Tangoku A, Yamamoto S, Oka M. Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience. Radiology 2004;230:543-552.
18. Carr HY. Steady-state free precession in nuclear magnetic resonance. Phys Rev 1958;112:1693-1701.
19. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-659.